News

Human organ chip research shows that a common antimalarial combination could reverse the negative effects of malnutrition in the female digestive tract that lead to low birth weight infants.

A collaborative team of researchers announced that they had successfully learned how to sabotage a key piece of machinery, called the Type 3 secretion system, that pathogens use to infect their host cells.

Screening for colon cancer reduces cancer rates by substantially more than previous analyses of randomized trials suggest, according to a study co-authored by an MIT economist that takes a new look at data from five trials.

A new review has called into question how effective opioids are for cancer pain, finding non-opioids, including aspirin, may be just as effective.

A newly developed vaccine could offer an inexpensive way to lower "bad" cholesterol, improving heart health.

KRAS is one of the most frequently mutated genes in cancer. Researchers expose its secret vulnerabilities, laying out a fresh blueprint for targeting ‘undruggable’ proteins.

A new study reports an AI-driven advance in biotechnology with implications for drug development, disease detection, and environmental monitoring.

In a Phase 2 trial of patients with chronic kidney disease, an experimental drug reduced albuminuria – albumin in the urine, a sign of kidney damage.

Researchers have predicted post-operative infections in liver transplant patients by analyzing the fecal microbiome, representing a leap forward in understanding the connection between the gut microbiome and health.

Medicinal psilocybin may prove to be an untapped therapeutic resource for a variety of psychiatric conditions identified by researchers at The Florey.